These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34229580)

  • 1. Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique.
    Sack DE; De Schacht C; Paulo P; Graves E; Emílio AM; Matino A; Fonseca CL; Aboobacar AU; Van Rompaey S; Audet CM
    Glob Health Action; 2021 Jan; 14(1):1940764. PubMed ID: 34229580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "We are in this together:" dyadic-level influence and decision-making among HIV serodiscordant couples in Tanzania receiving access to PrEP.
    Fonner VA; Ntogwisangu J; Hamidu I; Joseph J; Fields J; Evans E; Kilewo J; Bailey C; Goldsamt L; Fisher CB; O'Reilly KR; Ruta T; Mbwambo J; Sweat MD
    BMC Public Health; 2021 Apr; 21(1):720. PubMed ID: 33853559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated delivery of antiretroviral treatment and pre-exposure prophylaxis to HIV-1 serodiscordant couples in East Africa: a qualitative evaluation study in Uganda.
    Ware NC; Pisarski EE; Nakku-Joloba E; Wyatt MA; Muwonge TR; Turyameeba B; Asiimwe SB; Heffron RA; Baeten JM; Celum CL; Katabira ET
    J Int AIDS Soc; 2018 May; 21(5):e25113. PubMed ID: 29851436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the Longitudinal Predictive Relationship Between HIV Treatment Outcomes and Pre-exposure Prophylaxis Use by Serodiscordant Male Couples.
    Jin H; Biello K; Garofalo R; Lurie M; Sullivan PS; Stephenson R; Mimiaga MJ
    J Acquir Immune Defic Syndr; 2021 Jan; 86(1):38-45. PubMed ID: 33027155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with Use of Short-Term Pre-Exposure Prophylaxis for HIV Among Female Partners of Migrant Miners in Mozambique.
    Falcao J; Zerbe A; Lahuerta M; Baggaley R; Ahoua L; DiMattei P; Morales F; Ramiro I; El-Sadr WM
    AIDS Patient Care STDS; 2017 Dec; 31(12):528-534. PubMed ID: 29211515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond HIV prevention: everyday life priorities and demand for PrEP among Ugandan HIV serodiscordant couples.
    Nakku-Joloba E; Pisarski EE; Wyatt MA; Muwonge TR; Asiimwe S; Celum CL; Baeten JM; Katabira ET; Ware NC
    J Int AIDS Soc; 2019 Jan; 22(1):e25225. PubMed ID: 30657642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I Did Not Want to Give Birth to a Child Who has HIV": Experiences Using PrEP During Pregnancy Among HIV-Uninfected Kenyan Women in HIV-Serodiscordant Couples.
    Pintye J; Beima-Sofie KM; Kimemia G; Ngure K; Trinidad SB; Heffron RA; Baeten JM; Odoyo J; Mugo N; Bukusi EA; Kelley MC; John-Stewart GC
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):259-265. PubMed ID: 28777265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
    Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
    AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a storytelling intervention on the retention of serodiscordant couples in ART/PrEP services at antenatal clinic in Namacurra province in Zambézia, Mozambique.
    Audet CM; Graves E; Emílio AM; Matino A; Paulo P; Aboobacar AM; Fonseca CL; Van Rompaey S; De Schacht C
    Contemp Clin Trials Commun; 2021 Jun; 22():100782. PubMed ID: 34095604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to use short-term oral pre-exposure prophylaxis (PrEP) by migrant miners and female partners of migrant miners in Mozambique.
    Falcao J; Ahoua L; Zerbe A; di Mattei P; Baggaley R; Chivurre V; Mulondo P; Ramiro I; Dalal S; Morales F; O'Reilly K; El-Sadr W
    Cult Health Sex; 2017 Dec; 19(12):1389-1403. PubMed ID: 28468533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lay Social Resources for Support of Adherence to Antiretroviral Prophylaxis for HIV Prevention Among Serodiscordant Couples in sub-Saharan Africa: A Qualitative Study.
    Ware NC; Pisarski EE; Haberer JE; Wyatt MA; Tumwesigye E; Baeten JM; Celum CL; Bangsberg DR
    AIDS Behav; 2015 May; 19(5):811-20. PubMed ID: 25267114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of Pre-exposure Prophylaxis (PrEP) for HIV prevention among men living with HIV in the context of reproductive goals in South Africa: a qualitative study.
    Ntinga X; Isehunwa OO; Msimango LI; Smith PM; Matthews LT; Van Heerden A
    BMC Public Health; 2024 Feb; 24(1):553. PubMed ID: 38389039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C; Schnure M; Dent J; Glaubius R; Mahiane G; Hamilton M; Reidy M; Matse S; Njeuhmeli E; Castor D; Kripke K
    J Int AIDS Soc; 2020 Feb; 23(2):e25451. PubMed ID: 32112512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.